NASDAQ:PRLD | EBITDA | Prelude Therapeutics Inc

Complete source-backed ebitda history.

Available history
2019-12-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$13.79M
2025-12-31-$16.93M
2025-03-31-$34.17M
2024-12-31-$33.34M
2024-03-31-$33.92M
2023-12-31-$37.05M
2023-03-31-$28.84M
2022-12-31-$33.02M
2022-03-31-$29.98M
2021-12-31-$32.72M
2021-03-31-$21.81M
2020-12-31-$19.31M
2020-03-31-$9.61M
2019-12-31-$9.97M

Annual EBITDA

DateEBITDA
2025-12-31-$102.86M
2024-12-31-$137.94M
2023-12-31-$131.11M
2022-12-31-$122.22M
2021-12-31-$112.82M
2020-12-31-$58.22M
2019-12-31-$27.73M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.